As the world races to find a vaccine for COVID-19, our colleague Dr Cem Gun, an Emergency Medicine Physician at Acıbadem University Atakent Hospital, has bravely volunteered for the country’s first clinical trial. On 9 October, he was administered the first dose of a COVID-19 vaccine developed in China and approved for trial by the Health Institutes of Turkey, at a high-key milestone event.
On why he volunteered for this trial, Dr Cem Gun said, “As a healthcare worker, I fall into the high-risk group for COVID-19 infection. I decided to be vaccinated not only to protect myself but also my patients and loved ones. I made this decision with peace of mind as it is a controlled trial; it is currently in Phase 3, making it a tested and safe vaccine.”
The vaccine will be administered in two doses, and volunteers will be monitored on its effectiveness over a year.
The World Bank has approved US$12 billion in financing to help developing countries buy and distribute COVID-19 vaccines, tests and treatments, aiming to support the vaccination of up to 1 billion people.
Related Stories
Fortis Healthcare Expands Footprint with New 200-Bed Hospital in Greater Noida
See how Fortis strengthens its Delhi-NCR network and enhances access to quality care.
Fortis Manesar Breaks New Ground in Cardiac Care
Discover how a life-changing, minimally invasive procedure gave a 16-year-old patient a second chance
IHH Healthcare Debuts FutureHealth.Now Conference
See how we united visionary minds across healthcare, government and business to spark bold ideas and forge new partnerships that will push the boundaries of care at our inaugural global leadership conference.
Unveiling Our New IHH Healthcare Identity
Prince Court Medical Centre Performs Malaysia’s First Kelly Procedure
